CD4 and melanoma: Such future studies should consider investigating additional parameters such as lymphocyte subsets (CD4 T-cells and B-cells) and immunoglobulin G levels, which are more specific to immunosuppression for the purpose of identifying asymptomatic CLL among melanoma patients [31, 37].